K

Knotus Co Ltd
KOSDAQ:278650

Watchlist Manager
Knotus Co Ltd
KOSDAQ:278650
Watchlist
Price: 1 477 KRW 3.5% Market Closed
Market Cap: 128.5B KRW

Operating Margin

-15.5%
Current
Declining
by 6.9%
vs 3-y average of -8.6%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-15.5%
=
Operating Income
₩-11.1B
/
Revenue
₩71.5B

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-15.5%
=
Operating Income
₩-11.1B
/
Revenue
₩71.5B

Peer Comparison

Country Company Market Cap Operating
Margin
KR
Knotus Co Ltd
KOSDAQ:278650
120.5B KRW
Loading...
US
PerkinElmer Inc
LSE:0KHE
1.3T USD
Loading...
US
Thermo Fisher Scientific Inc
NYSE:TMO
240.3B USD
Loading...
US
Danaher Corp
NYSE:DHR
171B USD
Loading...
KR
Samsung Biologics Co Ltd
KRX:207940
46.3T KRW
Loading...
CH
Lonza Group AG
SIX:LONN
38.3B CHF
Loading...
US
IQVIA Holdings Inc
NYSE:IQV
41.1B USD
Loading...
CN
WuXi AppTec Co Ltd
SSE:603259
278.3B CNY
Loading...
US
Agilent Technologies Inc
NYSE:A
39.6B USD
Loading...
US
Mettler-Toledo International Inc
NYSE:MTD
29.5B USD
Loading...
US
Waters Corp
NYSE:WAT
23.6B USD
Loading...
No Stocks Found

Market Distribution

Lower than 85% of companies in Korea
Percentile
15th
Based on 2 615 companies
15th percentile
-15.5%
Low
-163 055.6% — -2.2%
Typical Range
-2.2% — 6.8%
High
6.8% — 22 874.8%
Distribution Statistics
Korea
Min -163 055.6%
30th Percentile -2.2%
Median 2.7%
70th Percentile 6.8%
Max 22 874.8%

Knotus Co Ltd
Glance View

KNOTUS Co. Ltd. engages in the provision of clinical research services. The company is headquartered in Incheon, Incheon. The company went IPO on 2019-11-27. is a Korea-based company principally engaged in the nonclinical experiment business. Along with subsidiaries, the Company operates its business through three segments. The Nonclinical Contract Research Organization (CRO) Business segment conducts nonclinical experiments on new developed substances such as new drugs, and tests the efficacy and pharmacodynamics of the substances. This segment also provides services including new drug development related equipment, software and analysis of experimental results. The Animal Laboratory Construction Business segment is engaged in the construction and design of animal laboratories and the supply of reagent consumables. The Pet Business segment is engaged in the development of animal medicines and the sale of pet supplies.

Knotus Co Ltd Intrinsic Value
HIDDEN
Show
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
-15.5%
=
Operating Income
₩-11.1B
/
Revenue
₩71.5B
What is Knotus Co Ltd's current Operating Margin?

The current Operating Margin for Knotus Co Ltd is -15.5%, which is below its 3-year median of -8.6%.

How has Operating Margin changed over time?

Over the last 3 years, Knotus Co Ltd’s Operating Margin has decreased from 9.1% to -15.5%. During this period, it reached a low of -22.3% on Dec 31, 2024 and a high of 9.1% on Aug 30, 2022.

Back to Top